- Home
- KURA vs ALEX Comparison
KURA vs ALEX Comparison
Compare KURA & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- ALEX
- Stock Information
- Founded
- KURA 2014
- ALEX 1870
- Country
- KURA United States
- ALEX United States
- Employees
- KURA N/A
- ALEX N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- ALEX Real Estate Investment Trusts
- Sector
- KURA Health Care
- ALEX Real Estate
- Exchange
- KURA Nasdaq
- ALEX Nasdaq
- Market Cap
- KURA 561.9M
- ALEX 1.3B
- IPO Year
- KURA N/A
- ALEX N/A
- Fundamental
- Price
- KURA $6.44
- ALEX $17.89
- Analyst Decision
- KURA Strong Buy
- ALEX Buy
- Analyst Count
- KURA 12
- ALEX 3
- Target Price
- KURA $24.50
- ALEX $23.00
- AVG Volume (30 Days)
- KURA 1.4M
- ALEX 386.9K
- Earning Date
- KURA 08-07-2025
- ALEX 07-24-2025
- Dividend Yield
- KURA N/A
- ALEX 5.02%
- EPS Growth
- KURA N/A
- ALEX 38.72
- EPS
- KURA N/A
- ALEX 0.85
- Revenue
- KURA $67,991,000.00
- ALEX $236,060,000.00
- Revenue This Year
- KURA $125.04
- ALEX N/A
- Revenue Next Year
- KURA $83.75
- ALEX $2.06
- P/E Ratio
- KURA N/A
- ALEX $21.13
- Revenue Growth
- KURA N/A
- ALEX 6.41
- 52 Week Low
- KURA $5.41
- ALEX $15.70
- 52 Week High
- KURA $23.48
- ALEX $20.30
- Technical
- Relative Strength Index (RSI)
- KURA 59.02
- ALEX 50.54
- Support Level
- KURA $5.65
- ALEX $17.66
- Resistance Level
- KURA $6.46
- ALEX $18.02
- Average True Range (ATR)
- KURA 0.26
- ALEX 0.30
- MACD
- KURA 0.07
- ALEX -0.03
- Stochastic Oscillator
- KURA 97.73
- ALEX 46.58
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.